Source: Urologic Oncology. Unidade: FM
Subjects: NEOPLASIAS DA BEXIGA, INFLAMAÇÃO, CITOCINAS, VACINAS VIRAIS, RATOS
ABNT
ANDRADE, Priscila M. et al. The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer. Urologic Oncology, v. 28, n. 5, p. 520-525, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.urolonc.2008.12.017. Acesso em: 01 maio 2024.APA
Andrade, P. M., Chade, D. C., Borra, R. C., Nascimento, I. P., Villanova, F. E., Leite, L. C. C., et al. (2010). The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer. Urologic Oncology, 28( 5), 520-525. doi:10.1016/j.urolonc.2008.12.017NLM
Andrade PM, Chade DC, Borra RC, Nascimento IP, Villanova FE, Leite LCC, Andrade E, Srougi M. The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer [Internet]. Urologic Oncology. 2010 ; 28( 5): 520-525.[citado 2024 maio 01 ] Available from: https://doi.org/10.1016/j.urolonc.2008.12.017Vancouver
Andrade PM, Chade DC, Borra RC, Nascimento IP, Villanova FE, Leite LCC, Andrade E, Srougi M. The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer [Internet]. Urologic Oncology. 2010 ; 28( 5): 520-525.[citado 2024 maio 01 ] Available from: https://doi.org/10.1016/j.urolonc.2008.12.017